Home > Healthcare > Medical Devices > Therapeutic Devices > Bone Graft Substitutes Market

Bone Graft Substitutes Market Trends

Report ID: GMI7993
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Bone Graft Substitutes Market Trends

The market are experiencing several notable trends that are shaping its growth and development. Factors such as rise in 3D printing technology, increasing use of allografts and xenografts, growing awareness of dental health and aesthetics, and a surging demand for minimally invasive surgical techniques, among other factors are propelling the industry expansion.

Further, a growing trend toward minimally invasive surgical techniques are influencing the market to improve their efficiency and aid better patient experience. Patients and healthcare providers were increasingly preferring procedures that involve smaller incisions, less tissue disruption, and shorter recovery times.
Moreover, ongoing research and development in biomaterials, including synthetic bone grafts and biologics, are driving innovation. Materials with enhanced biological properties and improved integration with host tissues are gaining notable importance in the industry.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Bone graft substitutes industry reached USD 3 billion in revenue in 2023 and is set to expand at 6.6% CAGR between 2024 and 2032 driven by the ongoing technological advancements and the growing number of surgical procedures.

The allograft type segment recorded USD 2 billion in revenue in 2023 and is estimated to record considerable growth through 2032 owing to their versatility for numerous medical conditions.

North America bone graft substitutes market size was USD 1.3 billion in 2023 and is estimated to grow at a robust growth rate from 2024 to 2032 attributed to the presence of aging population coupled with the growing number of orthopedic diseases in the region.

Some of the prominent bone graft substitute companies are AlloSource, Baxter International Inc., DePuy Synthes (Johnson & Johnson Inc.), Geistlich Pharma AG, Medtronic plc, NuVasive, Inc., Orthofix US LLC., OST Laboratories, Smith + Nephew, Stryker Corporation, and Zimmer Biomet Holdings, Inc.